These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15279060)

  • 1. Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population.
    Etter M; Mohr S; Garin C; Etter JF
    Schizophr Bull; 2004; 30(2):459-68. PubMed ID: 15279060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of smokers with a psychotic disorder and implications for smoking interventions.
    Baker A; Richmond R; Haile M; Lewin TJ; Carr VJ; Taylor RL; Constable PM; Jansons S; Wilhelm K; Moeller-Saxone K
    Psychiatry Res; 2007 Mar; 150(2):141-52. PubMed ID: 17289155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol consumption and the CAGE test in outpatients with schizophrenia or schizoaffective disorder and in the general population.
    Etter M; Etter JF
    Schizophr Bull; 2004; 30(4):947-56. PubMed ID: 15954200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking expectancies and intention to quit in smokers with schizophrenia, schizoaffective disorder and non-psychiatric controls.
    Tidey JW; Rohsenow DJ
    Schizophr Res; 2009 Dec; 115(2-3):310-6. PubMed ID: 19836210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perception of smoking risks and motivation to quit among nontreatment-seeking smokers with and without schizophrenia.
    Kelly DL; Raley HG; Lo S; Wright K; Liu F; McMahon RP; Moolchan ET; Feldman S; Richardson CM; Wehring HJ; Heishman SJ
    Schizophr Bull; 2012 May; 38(3):543-51. PubMed ID: 21041835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between smoking prevalence, stages of change, cigarette consumption, and quit attempts across the United States.
    Etter JF
    Prev Med; 2004 Mar; 38(3):369-73. PubMed ID: 14766121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit drug use in heavy smokers with and without schizophrenia.
    Mackowick KM; Heishman SJ; Wehring HJ; Liu F; McMahon RP; Kelly DL
    Schizophr Res; 2012 Aug; 139(1-3):194-200. PubMed ID: 22591779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation in China: findings from the 1996 national prevalence survey.
    Yang G; Ma J; Chen A; Zhang Y; Samet JM; Taylor CE; Becker K
    Tob Control; 2001 Jun; 10(2):170-4. PubMed ID: 11387539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Snowball sampling by mail: application to a survey of smokers in the general population.
    Etter JF; Perneger TV
    Int J Epidemiol; 2000 Feb; 29(1):43-8. PubMed ID: 10750602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subtyping general population smokers not intending to quit by stages to reduce smoking.
    Meyer C; Rumpf HJ; Schumann A; Hapke U; John U
    Nicotine Tob Res; 2004 Dec; 6(6):1043-50. PubMed ID: 15801578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of cigarette packages warning labels in relation to tobacco-smoking dependence and motivation to quit].
    Mannocci A; Antici D; Boccia A; La Torre G
    Epidemiol Prev; 2012; 36(2):100-7. PubMed ID: 22706360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls.
    Tidey JW; Rohsenow DJ; Kaplan GB; Swift RM
    Drug Alcohol Depend; 2005 Nov; 80(2):259-65. PubMed ID: 15869844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distributions of smokers by stage: international comparison and association with smoking prevalence.
    Etter JF; Perneger TV; Ronchi A
    Prev Med; 1997; 26(4):580-5. PubMed ID: 9245682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis.
    Cooper J; Mancuso SG; Borland R; Slade T; Galletly C; Castle D
    Aust N Z J Psychiatry; 2012 Sep; 46(9):851-63. PubMed ID: 22645396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention.
    Filia SL; Baker AL; Gurvich CT; Richmond R; Lewin TJ; Kulkarni J
    Psychiatry Res; 2014 Mar; 215(3):586-93. PubMed ID: 24485064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and clinical treatment of tobacco smokers enrolled in a VA substance use disorders clinic.
    Gass JC; Morris DH; Winters J; VanderVeen JW; Chermack S
    J Subst Abuse Treat; 2018 Jan; 84():1-8. PubMed ID: 29195588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social Disparities in Unaided Quit Attempts Among Daily Current and Former Smokers: Results From the 2010-2011 Tobacco Use Supplement to the Current Population Survey.
    McCarthy M; Siahpush M; Shaikh RA; Sikora Kessler A; Tibbits M
    Nicotine Tob Res; 2016 Aug; 18(8):1705-10. PubMed ID: 26764257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stages of motivation to change in smokers of the general population].
    Rumpf HJ; Meyer C; Hapke U; Dilling H; John U
    Gesundheitswesen; 1998 Oct; 60(10):592-7. PubMed ID: 9844296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM; Anthenelli RM; Morris CD; Treadow J; Thompson JR; Yunis C; George TP
    J Clin Psychiatry; 2012 May; 73(5):654-60. PubMed ID: 22697191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of spirituality and religiousness on smoking among patients with schizophrenia or schizo-affective disorder in Switzerland.
    Borras L; Mohr S; Brandt PY; Gillieron C; Eytan A; Huguelet P
    Int J Soc Psychiatry; 2008 Nov; 54(6):539-49. PubMed ID: 18974192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.